Krystal Biotech KRYS has outperformed the market over the previous 5 years by 15.05% on an annualized foundation producing a median annual return of 29.98%. Presently, Krystal Biotech has a market capitalization of $4.64 billion.
Shopping for $100 In KRYS: If an investor had purchased $100 of KRYS inventory 5 years in the past, it might be price $362.80 right now based mostly on a worth of $160.61 for KRYS on the time of writing.
Krystal Biotech’s Efficiency Over Final 5 Years
Lastly — what is the level of all this? The important thing perception to take from this text is to notice how a lot of a distinction compounded returns could make in your money development over a time frame.
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
Market Information and Knowledge delivered to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.

